Skip to content

Extended dosage of intravenous dexamethasone for management acute postoperative pain management in hip fracture surgery

Extended dosage of intravenous dexamethasone for management of acute postoperative pain in hip fracture surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251102002
Enrollment
60
Registered
2025-11-02
Start date
2021-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly patients undergoing hip fracture surgery multimodal analgesia visual analog scale morphine consumption cumulated ambulation score early ambulation

Interventions

Extended group received three doses of intravenous dexamethasone preoperatively, and 24 hours and 48 hours after the first dose. ,Standard group received two doses of intravenous dexamethasone preoper
Extended group,Standard group

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. closed fracture of the femoral neck or pertrochanteric region of the femur 2. age 60 years or older 3. scheduled for bipolar hemiarthroplasty or closed reduction and internal fixation with proximal femoral nail anti-rotation 4. underwent surgical intervention within 7 days following the diagnosis of hip fracture 5. preinjury independent ambulatory status without gait aids 6. willing to follow the study protocol and given their consents

Exclusion criteria

Exclusion criteria: 1. multiple trauma or fractures 2. had a previous hip fracture or surgery 3. had an underlying neuromuscular disorder or cognitive impairment that affected muscle function or made them unable to follow the postoperative protocol 4. had a pathologic fracture other than osteoporosis such as a metastatic fracture 5. had a contraindication or allergy to dexamethasone 6. diagnosed with diabetes mellitus and had HbA1c > 7.5% 7. were unable to follow the postoperative protocol 8. who wanted to withdraw by themselves.

Design outcomes

Primary

MeasureTime frame
Pain at rest and during motion 0-72 hours after surgery 10-point visual analog scale

Secondary

MeasureTime frame
Morphine consumptin 0-3 days after surgery mg,Blood sugar 0-3 days after surgery amount of morphine used,C-reactive protein 0-3 days after surgery blood test,Creatinine kinase 0-3 days after surgery blood test,Cumulated Ambulation Score 0-3 days after surgery performance-based scale,Barthel Index 0-24 weeks after surgery questionnaire,Harris Hip Score 0-24 weeks questionnaire,EQ-5D-5L 0-24 weeks questionnaire

Countries

Thailand

Contacts

Public ContactPaphon Sangasoongsong

Faculty of Medicine Ramathibodi Hospital, Mahidol University

paphonortho@gmail.com022011589

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026